tiprankstipranks
Trending News
More News >
IN8bio (INAB)
NASDAQ:INAB
US Market

IN8bio (INAB) Income Statement

Compare
448 Followers

IN8bio Income Statement

Last quarter (Q3 2025), IN8bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, IN8bio's net income was $-3.85M. See IN8bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -2.50M$ -1.10M$ 0.00$ 0.00
Operating Expenses
$ 30.44M$ 27.84M$ 28.52M$ 14.65M$ 8.56M
Depreciation and Amortization
$ 2.65M$ 2.50M$ 1.10M$ 788.00K$ 88.00K
EBITDA
$ -26.94M$ -27.51M$ -27.42M$ -13.87M$ -8.47M
Operating Income
$ -30.44M$ -30.34M$ -28.52M$ -14.65M$ -8.56M
Other Income/Expenses
$ 0.00$ 330.00K$ 0.00$ 0.00$ 0.00
Pretax Income
$ -30.44M$ -30.01M$ -28.52M$ -14.65M$ -8.56M
Net Income
$ -30.44M$ -30.01M$ -28.52M$ -14.65M$ -8.56M
Per Share Metrics
Basic EPS
$ -0.57$ -1.00$ -1.36$ -0.78$ -0.53
Diluted EPS
$ -0.57$ -1.00$ -1.36$ -0.78$ -0.53
Weighted Average Shares Outstanding
53.55M 29.86M 20.97M 18.78M 19.35M
Weighted Average Shares Outstanding (Diluted)
53.55M 29.86M 20.97M 18.78M 19.35M
Currency in USD

IN8bio Earnings and Revenue History